Skip to main content
Equibles

TARSONS · Tarsons Products Limited · Documents

Use TARSONS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TARSONS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
316.40 INR +4.40 (+1.41%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 5653 Avg daily vol (3M) 17.66K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call New Q2 2027 earnings call Held Nov 13, 2026
2026
Nov 13
Earnings call
Revenue growth exceeds 20% for second consecutive quarter

Tarsons Products Limited reported Q2 F527 standalone revenue growth of 25% and consolidated growth of 21% YOY, marking its second consecutive quarter of over 20% revenue growth, driven mainly by existing products and pharma and healthcare demand.

2 source passages
Good afternoon, everybody, and a warm welcome to the Q2 and H1FI27 earnings call of Tarsons Products Limited. We are pleased to deliver another quarter of strong performance, where our standalone revenue grew by 25% and consolidated revenue grew by 21% in Q2 F527 on a YOY basis. This marks our second consecutive quarter of over 20% revenue growth, reflecting the resilience of our business model, strong execution capabilities, Diversified product portfolio and branch length. Importantly, growth was largely driven by our existing product portfolio, with minimal contribution from new product categories. The uptick in inquiries, better customer engagement, and improvement in the demand momentum across our end-user industries, especially in the pharma and healthcare industry. Gives us the confidence that demand trajectory has the potential to sustain. Open the document at this passage
Showing 1–3 of 3 documents